Quantitative Drug Safety and Benefit Risk Evalu, Wang, Munsaka, Buchanan, Li..

CRC Press

Quantitative Drug Safety and Benefit Risk EvaluationPractical and Cross-Disciplinary Approaches\nAuthor(s): William Wang, Melvin Munsaka, James Buchanan, Judy Li\nFormat: Hardback\nPublisher: Taylor & Francis Ltd, United Kingdom\nImprint: CRC Press\nISBN-13: 9781138594067, 978-1138594067\nSynopsis\nQuantitative Methodologies and Process for Safety Monitoring and Ongoing Benefit Risk Evaluation provides a comprehensive coverage on safety monitoring methodologies, covering both global trends and regional initiatives. Pharmacovigilance has traditionally focused on the handling of individual adverse event reports however recently there had been a shift towards aggregate analysis to better understand the scope of product risks.\n\nWritten to be accessible not only to statisticians but also to safety scientists with a quantitative interest, this book aims to bridge the gap in knowledge between medical and statistical fields creating a truly multi-disciplinary approach that is very much.